HIGHLIGHTS
- who: Maria Jesus Rodrigo et al. from the Department of Ophthalmology, Miguel Servet University Hospital, Zaragoza, Spain have published the Article: Monitoring New Long-Lasting Intravitreal Formulation for Glaucoma with Vitreous Images Using Optical Coherence Tomography, in the Journal: Pharmaceutics 2021, 13, x FOR PEER REVIEW of /2021/
- what: The authors show that a glaucoma treatment combining a hypotensive and neuroprotective (IF) of brimonidine-Laponite (BRI/LAP) can be monitored non-invasively using vitreoretinal interface imaging captured with optical (OCT) over 24 weeks of follow-up. Given the non-parametric distribution of most of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.